Targeting and retention of HPV16 E7 to the endoplasmic reticulum enhances immune tumour protection
Open Access
- 1 April 2010
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (4) , 890-894
Abstract
The endoplasmic reticulum (ER) is where the major histocompatibility complex (MHC) class I molecules are loaded with epitopes to cause an immune cellular response. Most of the protein antigens are degraded in the cytoplasm to amino acids and few epitopes reach the ER. Antigen targeting of this organelle by Calreticulin (CRT) fusion avoids this degradation and enhances the immune response. We constructed a recombinant adenovirus to express the E7 antigen with an ER‐targeting signal peptide (SP) plus an ER retention signal (KDEL sequence). In cell‐culture experiments we demonstrated that this new E7 antigen, SP‐E7‐KDEL, targeted the ER. Infection of mice with this recombinant adenovirus that expresses SP‐E7‐KDEL showed interferon induction and tumour‐protection response, similar to that provided by an adenovirus expressing the E7 antigen fused to CRT. This work demonstrated that just by adding a SP and the KDEL sequence, antigens can be targeted and retained in the ER with a consequent enhancement of immune response and tumour protection. These results will have significant clinical applications.Keywords
This publication has 20 references indexed in Scilit:
- HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunityJournal of Dermatological Science, 2009
- Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell–Mediated Antitumor Immunity Induced by DNA VaccinationClinical Cancer Research, 2008
- Enhancement of Antibody Responses toBacillus anthracisProtective Antigen Domain IV by Use of Calreticulin as a Chimeric Molecular AdjuvantInfection and Immunity, 2008
- Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effectsGene Therapy, 2008
- Molecular machinations of the MHC-I peptide loading complexCurrent Opinion in Immunology, 2008
- Chimeric DNA Vaccine Reverses Morphine-Induced Immunosuppression and TumorigenesisMolecular Therapy, 2006
- A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effectsGene Therapy, 2005
- Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulinVaccine, 2004
- Targeting plasmid‐encoded proteins to the antigen presentation pathwaysImmunological Reviews, 2004
- Comparison of HPV DNA vaccines employing intracellular targeting strategiesGene Therapy, 2004